Finance

Lists
PUGBY:OTCMKTS
Puig Brands Unsponsored ADR Rep Ord Class B
$9.34
-1.27%
(-0.12) 1D
Aug 3, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PUGBY...
Open
$9.40
High
$9.40
Low
$9.34
Mkt. cap
2.89B
Avg. vol.
1.13K
Volume
1.26K
52-wk high
$11.95
52-wk low
$7.48
Shares outstanding
349.64M
No. of employees
12K
Open
$9.40
High
$9.40
Low
$9.34
Mkt. cap
2.89B
Avg. vol.
1.13K
Volume
1.26K
52-wk high
$11.95
52-wk low
$7.48
Shares outstanding
349.64M
No. of employees
12K
News stories
From sources across the web
Profile
Puig Brands, S.A. is a Spanish fashion and beauty company founded in 1914 by Antonio Puig Castelló in Barcelona, Catalonia, Spain, and still managed by the Puig family. Puig markets its products in 150 countries and is directly present in 32 of them, employing 11,124 people worldwide. In 2018, it had €2 billion in net revenues and €242 million in net income. Both in the fashion and fragrances sector, Puig operates under the Nina Ricci, Carolina Herrera, and Rabanne brands. In the fashion industry, it is also the majority shareholder of Jean Paul Gaultier and Dries Van Noten. In perfumes, it operates L'Artisan Parfumeur, Penhaligon's and under the license of the brands Christian Louboutin, Comme des Garçons, Adolfo Dominguez, Antonio Banderas, Shakira, Benetton and Byredo. In cosmetics it operates through the French Uriage, majority-owned subsidiares, the British Charlotte Tilbury and the Greek Apivita, and the Spanish joint-venture Isdin. Puig also operates under the brands Dr. Barbara Sturm, Kama Ayurveda and Loto del Sur. Wikipedia
About Puig Brands Unsponsored ADR Rep Ord Class B
CEOMarc Puig
Employees12.1K
Founded1914
Headquarters-
SectorPersonal care products
Websitepuig.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.37B
1.37B
1.18B
1.18B
Cost of goods sold
348.95M
348.95M
288.71M
288.71M
Cost of revenue
348.95M
348.95M
288.71M
288.71M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
782.34M
782.34M
718.08M
718.08M
Operating expense
770.37M
770.37M
718.32M
718.32M
Total operating expenses
1.12B
1.12B
1.01B
1.01B
Operating income
252.03M
252.03M
169.82M
169.82M
Other non operating income
-
-
-
-
EBT including unusual items
237.40M
237.40M
175.73M
175.73M
EBT excluding unusual items
247.24M
247.24M
175.50M
175.50M
Income tax expense
69.30M
69.30M
42.48M
42.48M
Effective tax rate
29.19%
29.19%
24.17%
24.17%
Other operating expenses
-11.97M
-11.97M
237.00K
237.00K
Net income
159.34M
159.34M
131.41M
131.41M
Net profit margin
11.62%
11.62%
11.17%
11.17%
Earnings per share
-
-
-
-
Interest and investment income
4.32M
4.32M
4.28M
4.28M
Interest expense
-16.11M
-16.11M
-14.56M
-14.56M
Net interest expenses
-11.78M
-11.78M
-10.28M
-10.28M
Depreciation and amortization charges
-
-
-
-
EBITDA
279.40M
279.40M
208.25M
208.25M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps